ASTRO 2025 Speaker and Poster Sessions
We welcome you to stop by Booth #2310 to connect with our team and learn more about our latest offerings and initiatives
Clinical Scorecard: ASTRO 2025 Speaker and Poster Sessions
At a Glance
| Category | Detail |
|---|
| Condition | Various cancers including NSCLC, sarcomas, breast, genitourinary, gastrointestinal, and esophageal cancers |
| Key Mechanisms | Adaptive radiation therapy techniques including CT-guided online adaptive radiation therapy (CT-ART), stereotactic body radiation therapy, and chemoradiation approaches |
| Target Population | Cancer patients undergoing radiation therapy, including those with locally advanced, recurrent, or metastatic disease |
| Care Setting | Radiation oncology clinics and academic medical centers |
Key Highlights
- Focus on adaptive radiation treatment planning and challenges in implementation
- Presentation of clinical and translational research including tumor growth dynamics and prognostic factors
- Discussions on patient safety, supportive care, and global oncology including vaccine equity
Guideline-Based Recommendations
Diagnosis
- Utilize imaging and clinical assessment to guide adaptive radiation therapy planning
- Incorporate molecular and clinical markers such as BRCA1/2 status for prognostic evaluation
Management
- Implement CT-guided online adaptive radiation therapy (CT-ART) to optimize treatment delivery
- Consider stereotactic body radiation therapy for re-irradiation of recurrent sarcomas
- Use chemoradiation protocols with agents like 5-aminolevulinic acid to enhance tumor control
- Apply salvage HDR brachytherapy in appropriate genitourinary cancer cases
Monitoring & Follow-up
- Monitor tumor response and toxicity including esophagitis rates during chemoradiation
- Evaluate pathologic complete response following clinical complete response in esophageal carcinoma
Risks
- Be aware of potential severe esophagitis with chemoradiation, though low rates reported with PLDR chemoradiation
- Consider workflow challenges and clinic resource management when implementing adaptive radiation therapy
Patient & Prescribing Data
Patients with locally advanced, recurrent, or metastatic cancers undergoing radiation therapy
Adaptive radiation therapy techniques and chemoradiation regimens demonstrate potential for improved tumor control with manageable toxicity profiles
Clinical Best Practices
- Engage multidisciplinary teams for adaptive radiation therapy planning and delivery
- Incorporate patient-specific factors including genetic markers in treatment decision-making
- Utilize clinical trial data and emerging evidence to guide radiation dose fractionation and modality selection
- Address supportive care needs and patient safety proactively during treatment
- Promote education and resource sharing within radiation oncology communities
References
